As a psychiatrist and addictionologist, Dr. Arturo Taca has long been at the forefront of developing innovative solutions for persons struggling with mental health issues such as addiction and treatment-resistant depression.

Dr. Taca graduated from The University of the East Medical School in Manila, Philippines and completed his psychiatric residency training at St. Louis University School of Medicine, where he was the Chief Resident of the Department of Psychiatry. He is adjunct faculty at St. Louis University and continues to teach and supervise residents and medical students. Dr. Taca is also involved in the newly formed Addiction Medicine Fellowship at St. Louis University through the Department of Family Medicine.

Dr. Taca is triple board-certified and is a Diplomate in Psychiatry, Addiction Medicine, and Preventative Medicine. Additionally, Dr. Taca is a distinguished Fellow of the American Society of Addiction Medicine (ASAM), where he served as the president of ASAM – Midwest Chapter. Before his presidency, he was elected to the Executive Board of American Society of Addiction Medicine (ASAM) as alternate Regional Director for Region VII which covers the 7 states of AR, OK, KS, LA, MO, NE, and TX.

Dr. Taca founded INSynergy in response to a dire need to provide effective, evidence-based, and cost-effective treatment solutions for motivated persons struggling with addictions. Dr. Taca and his team at INSynergy were instrumental in developing a unique protocol using a percutaneous nerve stimulator, the NSS-2 Bridge, to reduce symptoms of opioid withdrawal. The NSS-2 Bridge was the first device granted by the FDA to be used specifically to reduce symptoms of opioid withdrawal.

His interest in the field of neurostimulation began in the early 2000s when he was involved in the Vagus Nerve Stimulation (VNS) trials at St. Louis University School of Medicine as a resident. Dr. Taca was one of the first providers to offer Transcranial Magnetic Stimulation (TMS) services to the St. Louis area in 2014. TMS is currently approved for Major Depression, OCD, nicotine dependence, and is being studied in opioid addiction, bipolar depression, and other psychiatric conditions. Cranial nerve stimulators such as the NSS-2 Bridge, Drug Relief, and S.T. Genesis are FDA cleared to be used in opioid withdrawal and chronic pain. Vagus nerve stimulators have been approved for the treatment of Major Depression and Epilepsy. Dr. Taca believes that these new neurostimulation treatments will play a major role in difficult-to-treat neuropsychiatric conditions.

In addition to his board certifications, Dr. Taca was voted one of the “Best Doctors of America in Psychiatry and Addiction Psychiatry” by his peers. Only 5% of all doctors in the U.S. are recognized with this distinction and are selected by a consensus of more than one million votes cast by doctors across the country. He has been a “Best Doc” since 2009